Pharmala Biotech Holdings Inc. (MDXXF) News
Track canonical SquawkNews coverage tagged to MDXXF, Pharmala Biotech Holdings Inc.. This hub brings together deduplicated headlines about otc markets otcqb, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on a license agreement, enrollment completion and a patent filing. PHARMALA, JUPITER ENTER LICENSE AGREEMENT: PharmAla Biotech
EQUITY | Jul 23, 2026, 03:07 PM UTC
L
Psychedelic: Compass Pathways reports six-month data for psilocybin drug
In this week's "Psychedelic," recurring series focused on psychedelic stock news, looks back on study results, drug delivery evaluation and last patient dosing. COMPASS PATHWAYS REPORTS SIX-MONTH DATA FROM COMP006 TRIAL:
EQUITY | Jul 09, 2026, 01:49 PM UTC